QuickView for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=F814328285108F7A4EA0DA28CFE696D7;jsessionid=502E776C630F24248151AAEED05D5B46;jsessionid=FE390919606FA9CDF00B0C61A4202833;jsessionid=334BF4959346DFAAAC6638C54DCCCC93;jsessionid=F66F47001557A0E969FED97CF34A09D4;jsessionid=14B2AB536CC7C8C7F2095E8DC9AF3E96;jsessionid=90E1E717A16C7901F5E2068F9530051C;jsessionid=6B53D18FB1331F7CAD21D79DFB733C08 (gene)

1. Ataxin-2 sequesters Raptor into aggregates and impairs cellular mTORC1 signaling.
2. ATXN2 is a target of N-terminal proteolysis.
3. ATXN2 intermediate expansions in amyotrophic lateral sclerosis.
4. TDP-43 impairs sleep in Drosophila through Ataxin-2-dependent metabolic disturbance.
5. Missense mutation in ATXN2 gene (c.2860C > T) in an amyotrophic lateral sclerosis patient with aggre…

There were no clinical trials for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=F814328285108F7A4EA0DA28CFE696D7;jsessionid=502E776C630F24248151AAEED05D5B46;jsessionid=FE390919606FA9CDF00B0C61A4202833;jsessionid=334BF4959346DFAAAC6638C54DCCCC93;jsessionid=F66F47001557A0E969FED97CF34A09D4;jsessionid=14B2AB536CC7C8C7F2095E8DC9AF3E96;jsessionid=90E1E717A16C7901F5E2068F9530051C;jsessionid=6B53D18FB1331F7CAD21D79DFB733C08